These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34785787)

  • 1. Precision medicine in IBD: genes, drugs, bugs and omics.
    Mao R; Chen M
    Nat Rev Gastroenterol Hepatol; 2022 Feb; 19(2):81-82. PubMed ID: 34785787
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
    Verstockt B; Noor NM; Marigorta UM; Pavlidis P; Deepak P; Ungaro RC;
    J Crohns Colitis; 2021 Sep; 15(9):1431-1442. PubMed ID: 33730756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.
    Fiocchi C; Dragoni G; Iliopoulos D; Katsanos K; Ramirez VH; Suzuki K;
    J Crohns Colitis; 2021 Sep; 15(9):1410-1430. PubMed ID: 33733656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in IBD Research: Precision Medicine.
    Denson LA; Curran M; McGovern DPB; Koltun WA; Duerr RH; Kim SC; Sartor RB; Sylvester FA; Abraham C; de Zoeten EF; Siegel CA; Burns RM; Dobes AM; Shtraizent N; Honig G; Heller CA; Hurtado-Lorenzo A; Cho JH
    Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S31-S39. PubMed ID: 31095701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and Lipidomics in Inflammatory Bowel Disease Research: From Mechanistic Insights to Biomarker Identification.
    Titz B; Gadaleta RM; Lo Sasso G; Elamin A; Ekroos K; Ivanov NV; Peitsch MC; Hoeng J
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology.
    Liu XY; Tang H; Zhou QY; Zeng YL; Chen D; Xu H; Li Y; Tan B; Qian JM
    World J Gastroenterol; 2023 Jan; 29(2):272-285. PubMed ID: 36687128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the threshold of personalized medicine in inflammatory bowel disease: Next generation genetic predictors.
    Parkes M
    J Gastroenterol Hepatol; 2018 Sep; 33 Suppl 3():5-6. PubMed ID: 30187553
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Prediction and Prevention of Inflammatory Bowel Disease.
    Torres J; Halfvarson J; Rodríguez-Lago I; Hedin CRH; Jess T; Dubinsky M; Croitoru K; Colombel JF
    J Crohns Colitis; 2021 Sep; 15(9):1443-1454. PubMed ID: 33730755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.
    Stylianou E
    Mol Diagn Ther; 2018 Feb; 22(1):11-23. PubMed ID: 28900867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Pediatric Inflammatory Bowel Disease.
    Spencer EA; Dubinsky MC
    Pediatr Clin North Am; 2021 Dec; 68(6):1171-1190. PubMed ID: 34736583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in IBD Research.
    Inflamm Bowel Dis; 2019 May; 25(Suppl 2):S1-S4. PubMed ID: 31095705
    [No Abstract]   [Full Text] [Related]  

  • 12. IBD 2020: Right therapy, right patient, right time - Choosing wisely: Conclusions.
    Sparrow M
    J Gastroenterol Hepatol; 2021 Apr; 36 Suppl 1():35-36. PubMed ID: 33817856
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions.
    Dart RJ; Ellul P; Scharl M; Lamb CA
    J Crohns Colitis; 2021 Sep; 15(9):1407-1409. PubMed ID: 33783484
    [No Abstract]   [Full Text] [Related]  

  • 14. IBD in 2016: Biologicals and biosimilars in IBD - the road to personalized treatment.
    Gecse KB; Lakatos PL
    Nat Rev Gastroenterol Hepatol; 2017 Feb; 14(2):74-76. PubMed ID: 28074074
    [No Abstract]   [Full Text] [Related]  

  • 15. Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease.
    Li J; Zhou H; Fu X; Zhang M; Sun F; Fan H
    Immunol Lett; 2021 Apr; 232():39-44. PubMed ID: 33582183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the need for comparative effectiveness studies in IBD?
    Flasar MH; Cross RK
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):851-4. PubMed ID: 25096481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IBD and the gut microbiota--from bench to personalized medicine.
    Bellaguarda E; Chang EB
    Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD.
    Noor NM; Sousa P; Paul S; Roblin X
    Inflamm Bowel Dis; 2022 Aug; 28(8):1254-1264. PubMed ID: 34480558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big data in IBD: a look into the future.
    Olivera P; Danese S; Jay N; Natoli G; Peyrin-Biroulet L
    Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):312-321. PubMed ID: 30659247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IBD: advances in pathogenesis, complications, diagnosis, and therapy.
    Fiocchi C
    Curr Opin Gastroenterol; 2012 Jul; 28(4):297-300. PubMed ID: 22678450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.